IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 138 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $21,924,119 | +59619.2% | 646,920 | +14.5% | 0.04% | -36.2% |
| Q1 2024 | $36,712 | +55.7% | 564,800 | +63.7% | 0.06% | +61.1% |
| Q4 2023 | $23,577 | -0.4% | 345,100 | -24.4% | 0.04% | -10.0% |
| Q3 2023 | $23,682 | -11.7% | 456,300 | +2.0% | 0.04% | +2.6% |
| Q2 2023 | $26,820 | +22.0% | 447,300 | +0.6% | 0.04% | +34.5% |
| Q1 2023 | $21,981 | +26.2% | 444,600 | +45.7% | 0.03% | +20.8% |
| Q4 2022 | $17,412 | -99.6% | 305,100 | +221.8% | 0.02% | +300.0% |
| Q3 2022 | $4,450,000 | +134.3% | 94,800 | +86.2% | 0.01% | +200.0% |
| Q2 2022 | $1,899,000 | +771.1% | 50,900 | +597.3% | 0.00% | – |
| Q1 2022 | $218,000 | – | 7,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |